IN2014DN05281A - - Google Patents

Info

Publication number
IN2014DN05281A
IN2014DN05281A IN5281DEN2014A IN2014DN05281A IN 2014DN05281 A IN2014DN05281 A IN 2014DN05281A IN 5281DEN2014 A IN5281DEN2014 A IN 5281DEN2014A IN 2014DN05281 A IN2014DN05281 A IN 2014DN05281A
Authority
IN
India
Prior art keywords
compound
reacted
pyrazolo
fluorobenzyl
pyridin
Prior art date
Application number
Other languages
English (en)
Inventor
Jin Li
Xiaoyu Yang
Jingwei Zhu
Minmin Yang
Xihan Wu
Original Assignee
Pharmablock Nanjing R & D Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmablock Nanjing R & D Co Ltd filed Critical Pharmablock Nanjing R & D Co Ltd
Publication of IN2014DN05281A publication Critical patent/IN2014DN05281A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN5281DEN2014 2011-12-12 2012-11-28 IN2014DN05281A (enrdf_load_stackoverflow)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201110414004.0A CN102491974B (zh) 2011-12-12 2011-12-12 1-(2-氟苄基)-1H-吡唑并[3,4-b]吡啶-3-甲脒盐酸盐的合成方法
PCT/CN2012/085451 WO2013086935A1 (zh) 2011-12-12 2012-11-28 1-(2-氟苄基)-1H -吡唑并[3,4- b]吡啶-3 -甲脒盐酸盐的合成方法

Publications (1)

Publication Number Publication Date
IN2014DN05281A true IN2014DN05281A (enrdf_load_stackoverflow) 2015-04-03

Family

ID=46183843

Family Applications (1)

Application Number Title Priority Date Filing Date
IN5281DEN2014 IN2014DN05281A (enrdf_load_stackoverflow) 2011-12-12 2012-11-28

Country Status (7)

Country Link
US (1) US8957210B2 (enrdf_load_stackoverflow)
JP (1) JP5791825B2 (enrdf_load_stackoverflow)
CN (1) CN102491974B (enrdf_load_stackoverflow)
DE (1) DE112012005176B4 (enrdf_load_stackoverflow)
IL (1) IL233066B (enrdf_load_stackoverflow)
IN (1) IN2014DN05281A (enrdf_load_stackoverflow)
WO (1) WO2013086935A1 (enrdf_load_stackoverflow)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102491974B (zh) 2011-12-12 2013-08-07 南京药石药物研发有限公司 1-(2-氟苄基)-1H-吡唑并[3,4-b]吡啶-3-甲脒盐酸盐的合成方法
CN104086545A (zh) * 2014-07-29 2014-10-08 安徽联创药物化学有限公司 1-(2-氟苄基)-1H-吡唑并[3,4-b]吡啶-3-甲脒盐酸盐的合成方法
CN105237531A (zh) * 2015-10-15 2016-01-13 湖南华腾制药有限公司 一种利奥西呱中间体的制备方法及其中间体化合物
MX2018007152A (es) 2015-12-14 2018-08-15 Ironwood Pharmaceuticals Inc Uso de estimuladores de guanilato ciclasa soluble (sgc) para el tratamiento de la disfuncion del esfinter gastrointestinal.
WO2018111795A2 (en) 2016-12-13 2018-06-21 Ironwood Pharmaceuticals, Inc. Use of sgc stimulators for the treatment of esophageal motility disorders
MX2021000363A (es) 2018-07-11 2021-04-29 Cyclerion Therapeutics Inc Uso de estimuladores de la guanilato ciclasa soluble (sgc) para el tratamiento de trastornos mitocondriales.
CN115947689B (zh) * 2022-09-23 2025-08-29 湖南华腾制药有限公司 一种连续流微反应器合成利奥西呱中间体的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR031176A1 (es) * 2000-11-22 2003-09-10 Bayer Ag Nuevos derivados de pirazolpiridina sustituidos con piridina
DE10220570A1 (de) * 2002-05-08 2003-11-20 Bayer Ag Carbamat-substituierte Pyrazolopyridine
CA2716952A1 (en) 2008-02-29 2009-09-11 Array Biopharma Inc. Pyrazole [3,4-b] pyridine raf inhibitors
AU2009308687A1 (en) * 2008-11-03 2010-05-06 Chemocentryx, Inc. Compounds for the treatment of osteoporosis and cancers
CN101648909B (zh) * 2009-09-14 2011-10-05 南京第一农药集团有限公司 一种氯代吡啶在无配体钯催化下制备氰基吡啶的方法
US20110225969A1 (en) 2010-03-19 2011-09-22 Gm Global Technology Operations, Inc. Compressor bypass to exhaust for particulate trap regeneration
DK2576548T3 (en) 2010-05-26 2015-09-28 Adverio Pharma Gmbh USE OF sGC stimulators, sGC activators alone and in combination with PDE5 inhibitors for treating systemic sclerosis (SSc)
DE102010021637A1 (de) 2010-05-26 2011-12-01 Bayer Schering Pharma Aktiengesellschaft Substituierte 5-Fluor-1H-Pyrazolopyridine und ihre Verwendung
MX2012013774A (es) * 2010-05-27 2012-12-17 Merck Sharp & Dohme Activadores de guanilato ciclasa soluble.
PL2699576T3 (pl) * 2011-04-22 2016-05-31 Pfizer Pochodne pirazolospiroketonu do zastosowania jako inhibitory karboksylazy acetylo-COA
AU2012300844B2 (en) * 2011-09-02 2017-03-30 Bayer Intellectual Property Gmbh Substituted annellated pyrimidine and the use thereof
CN102491974B (zh) 2011-12-12 2013-08-07 南京药石药物研发有限公司 1-(2-氟苄基)-1H-吡唑并[3,4-b]吡啶-3-甲脒盐酸盐的合成方法

Also Published As

Publication number Publication date
CN102491974B (zh) 2013-08-07
DE112012005176B4 (de) 2018-10-11
IL233066A0 (en) 2014-07-31
IL233066B (en) 2019-01-31
JP2015500248A (ja) 2015-01-05
US8957210B2 (en) 2015-02-17
CN102491974A (zh) 2012-06-13
WO2013086935A1 (zh) 2013-06-20
DE112012005176T5 (de) 2014-08-28
JP5791825B2 (ja) 2015-10-07
US20140309425A1 (en) 2014-10-16

Similar Documents

Publication Publication Date Title
IN2014DN05281A (enrdf_load_stackoverflow)
IL196894A0 (en) Process for preparing 3-dihalomethylpyrazole-4-carboxylic acid derivatives
NZ603268A (en) Process for synthesizing oxidized lactam compounds
EP4023641A3 (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
PH12015501226A1 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing the same
MX2009008662A (es) Metodo para la produccion de 2,3,3,3-tetrafluoropropeno.
MX347947B (es) Metodo y sistema para preparar cloruro de hidrogeno de alta pureza.
MY158251A (en) Method for the preparation of nalmefene hydrochloride
TN2012000506A1 (en) Process for the preparation of pleuromutilins
MX342969B (es) Cloracion de carbohidratos y derivados de carbohidratos.
WO2009063856A1 (ja) セルロースエーテル誘導体の製造方法
WO2011004980A3 (ko) 트리사이클릭 유도체의 제조방법
WO2012070747A3 (ko) 폴리유산과 고전도성 폴리유산 중합체의 제조방법 및 고전도성 폴리유산 중합체의 제조장치
WO2011114210A3 (en) Processes for the preparation of linezolid
NZ603653A (en) Processes for the preparation of dipyridamole
MX357865B (es) Procedimientos eficientes para preparación a gran escala de agentes antitumorales de fosfaplatinos.
NZ608028A (en) Improved method for preparing dipeptidyl peptidase-iv inhibitor and intermediate
MX2012000431A (es) Procedimientos para 3-amino-5-oxo-4,5-dihidro-[1,2,4]triazinas sustituidas.
MX2012001675A (es) Procedimiento para preparar 2,4-dioxotetrahidrofuran-3-carboxilato s.
NZ589867A (en) Process for the synthesis of n-demethylated morphinane compounds
CN102020575A (zh) 一种左旋肉碱的合成方法
WO2011048612A3 (en) Process for preparation of propargylated aminoindans or pharmaceutically acceptable salts thereof
WO2008111521A1 (ja) ヨウ素化剤の製造方法、および芳香族ヨウ素化合物の製造方法
IL193276A0 (en) Process for preparing 1-halo-2,7-naphthyridinyl derivatives
TW200626606A (en) Process for preparing phosphorus compounds having phosphate-phosphonate bond